Tweet
<img alt="" height="1" width="1" />
Amylin, Alkermes say diabetes drug safe for heart
BusinessWeek
Shares of Amylin and Alkermes Inc. climbed Thursday after the companies said their once-per-week diabetes medication appears safe for the heart, addressing concerns that delayed its federal review last year. The drug, Bydureon, is designed to be a ...
US Stock Futures: HOT STOCKS TO WATCHWall Street Journal
Amylin, Alkermes Shares Up As Diabetic Drug Bydureon Study Meets Endpoint InRTT News
Exenatide reduced HF risk by half in type 2 diabetesCardiology Today
SignOnSanDiego.com -MarketWatch (press release) -Xconomy
all 42 news articles »
More...